You are here

Study Evaluating rFIX; BeneFIX in Severe Hemophilia B

Last updated on March 11, 2019

FOR MORE INFORMATION
Study Location
Aurora, Colorado, 80262 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hemophilia B
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0-5
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Severe hemophilia B

- Less than 5 years of age

- In the investigator's judgment, the patient and/or caregiver will be compliant to
study procedures

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- A currently detectable FIX inhibitor. A family history of inhibitors will not exclude
the patient.

- Impaired liver function

- Impaired renal function

NCT00037557
Pfizer
Completed
Study Evaluating rFIX; BeneFIX in Severe Hemophilia B

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now